ImmunXperts
ActiveSummary
The computed 12-month bankruptcy probability of ImmunXperts is 1.7% (moderate). The 2024 annual accounts show negative equity (-€1.6m) and a net result of -€3.0m. Equity remains stable across the filed financial years (±1.3% per year). Its solvency ranks better than 9% of 242 sector peers (NACE 72, financial year 2024). The company has been active since 2014 and the Belgian Official Gazette contains no insolvency or warning signals.
Articles of association
- PurposeThe activities the company may carry out under its articles.
- “Le développement et la fourniture de services d'analyse ou de prédiction d'effets secondaires des produits pharmaceutiques... [full object…” (deed in French)
Read from the deeds: 1 provision, deed of 16-04-2020